Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 3 results.
User Information
Export Records
  1. 1.   Oral recombinant methioninase combined with oxaliplatinum and 5-fluorouracil regressed a colon cancer growing on the peritoneal surface in a patient-derived orthotopic xenograft mouse model
  2. Park, Jun Ho; Han, Qinghong; Zhao, Ming; Tan, Yuying; Higuchi, Takashi; Yoon, Sang Nam; Sugisawa, Norihiko; Yamamoto, Jun; Bouvet, Michael; Clary, Bryan; Singh,Shree Ram; Hoffman, Robert M
  3. Tissue & cell. 2019, Dec; 61: 109-114.
  1. 2.   Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model
  2. Oshiro, Hiromichi; Tome, Yasunori; Kiyuna, Tasuku; Yoon, Sang Nam; Lwin, Thinzar M; Han, Qinghong; Tan, Yuying; Miyake, Kentaro; Higuchi, Takashi; Sugisawa, Norihiko; Katsuya, Yuki; Park, Jun Ho; Zang, Zhiying; Razmjooei, Sahar; Bouvet, Michael; Clary, Bryan; Singh,Shree Ram; Kanaya, Fuminori; Nishida, Kotaro; Hoffman, Robert M
  3. Anticancer research. 2019, Sep; 39(9): 4667-4671.
  1. 3.   Regorafenib regressed a doxorubicin-resistant Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude mouse model
  2. Miyake, Kentaro; Kiyuna, Tasuku; Kawaguchi, Kei; Higuchi, Takashi; Oshiro, Hiromichi; Zhang, Zhiying; Wangsiricharoen, Sintawat; Razmjooei, Sahar; Li, Yunfeng; Nelson, Scott D; Murakami, Takashi; Hiroshima, Yukihiko; Matsuyama, Ryusei; Bouvet, Michael; Chawla, Sant P; Singh, Shree Ram; Endo, Itaru; Hoffman, Robert M
  3. Cancer chemotherapy and pharmacology. 2019, May; 83(5): 809-815.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel